These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 22286122)

  • 1. Multiple roles of class I HDACs in proliferation, differentiation, and development.
    Reichert N; Choukrallah MA; Matthias P
    Cell Mol Life Sci; 2012 Jul; 69(13):2173-87. PubMed ID: 22286122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.
    Li Z; Zhu WG
    Int J Biol Sci; 2014; 10(7):757-70. PubMed ID: 25013383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation.
    Chen S; Bellew C; Yao X; Stefkova J; Dipp S; Saifudeen Z; Bachvarov D; El-Dahr SS
    J Biol Chem; 2011 Sep; 286(37):32775-89. PubMed ID: 21778236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylases as targets for treatment of multiple diseases.
    Tang J; Yan H; Zhuang S
    Clin Sci (Lond); 2013 Jun; 124(11):651-62. PubMed ID: 23414309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
    Yoshida M; Shimazu T; Matsuyama A
    Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
    Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylases and mechanisms of regulation of gene expression.
    Chen HP; Zhao YT; Zhao TC
    Crit Rev Oncog; 2015; 20(1-2):35-47. PubMed ID: 25746103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protected from the inside: endogenous histone deacetylase inhibitors and the road to cancer.
    Di Marcotullio L; Canettieri G; Infante P; Greco A; Gulino A
    Biochim Biophys Acta; 2011 Apr; 1815(2):241-52. PubMed ID: 21277938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The many roles of histone deacetylases in development and physiology: implications for disease and therapy.
    Haberland M; Montgomery RL; Olson EN
    Nat Rev Genet; 2009 Jan; 10(1):32-42. PubMed ID: 19065135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension.
    Kee HJ; Kim I; Jeong MH
    Biochem Pharmacol; 2022 Aug; 202():115111. PubMed ID: 35640713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylases in kidney development: implications for disease and therapy.
    Chen S; El-Dahr SS
    Pediatr Nephrol; 2013 May; 28(5):689-98. PubMed ID: 22722820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells.
    Humphrey GW; Wang YH; Hirai T; Padmanabhan R; Panchision DM; Newell LF; McKay RD; Howard BH
    Differentiation; 2008 Apr; 76(4):348-56. PubMed ID: 18021260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription and beyond: the role of mammalian class I lysine deacetylases.
    Moser MA; Hagelkruys A; Seiser C
    Chromosoma; 2014 Mar; 123(1-2):67-78. PubMed ID: 24170248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer.
    Chiaradonna F; Cirulli C; Palorini R; Votta G; Alberghina L
    Antioxid Redox Signal; 2015 Jul; 23(1):30-50. PubMed ID: 24483782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors and cell death.
    Zhang J; Zhong Q
    Cell Mol Life Sci; 2014 Oct; 71(20):3885-901. PubMed ID: 24898083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class II histone deacetylases: versatile regulators.
    Verdin E; Dequiedt F; Kasler HG
    Trends Genet; 2003 May; 19(5):286-93. PubMed ID: 12711221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
    Bai G; Wei D; Zou S; Ren K; Dubner R
    Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.
    Gallinari P; Di Marco S; Jones P; Pallaoro M; Steinkühler C
    Cell Res; 2007 Mar; 17(3):195-211. PubMed ID: 17325692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HDACs in normal and malignant hematopoiesis.
    Wang P; Wang Z; Liu J
    Mol Cancer; 2020 Jan; 19(1):5. PubMed ID: 31910827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDACi--going through the mechanisms.
    Wanczyk M; Roszczenko K; Marcinkiewicz K; Bojarczuk K; Kowara M; Winiarska M
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):340-59. PubMed ID: 21196174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.